HSBC Holdings’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$905K Sell
27,594
-3,260
-11% -$138K ﹤0.01% 1924
2025
Q4
$1.43M Buy
30,854
+13,520
+78% +$566K ﹤0.01% 1738
2025
Q3
$613K Buy
17,334
+2,809
+19% +$97.6K ﹤0.01% 2003
2025
Q2
$427K Sell
14,525
-9,162
-39% -$261K ﹤0.01% 2233
2025
Q1
$703K Buy
23,687
+6,808
+40% +$208K ﹤0.01% 1914
2024
Q4
$483K Sell
16,879
-576
-3% -$19.1K ﹤0.01% 2201
2024
Q3
$675K Sell
17,455
-3,133
-15% -$112K ﹤0.01% 1866
2024
Q2
$663K Sell
20,588
-726
-3% -$25.2K ﹤0.01% 1845
2024
Q1
$827K Buy
21,314
+13,570
+175% +$475K ﹤0.01% 1862
2023
Q4
$239K Buy
+7,744
New +$194K ﹤0.01% 2386
2023
Q2
Sell
-8,284
Closed -$201K 2587
2023
Q1
$201K Sell
8,284
-5,603
-40% -$149K ﹤0.01% 2395
2022
Q4
$322K Buy
13,887
+1,800
+15% +$36.3K ﹤0.01% 2502
2022
Q3
$197K Buy
12,087
+1,778
+17% +$31.4K ﹤0.01% 2635
2022
Q2
$183K Buy
+10,309
New +$173K ﹤0.01% 2910
2021
Q3
Sell
-13,235
Closed -$316K 3012
2021
Q2
$316K Buy
13,235
+3,950
+43% +$91.3K ﹤0.01% 2481
2021
Q1
$222K Buy
+9,285
New +$221K ﹤0.01% 2492

Other funds holding COLL

HSBC Holdings's COLL Position: Q1 2026 in Review

HSBC Holdings reduced its Collegium Pharmaceutical (COLL) stake by 11% in Q1 2026, selling an estimated $138K and leaving 27,594 shares worth $905K. The position accounts for ﹤0.01% of the portfolio, ranked #1924.

HSBC Holdings first reported a position in COLL in Q1 2021 and has held it in 16 quarters since. The position peaked at $1.43M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • HSBC Holdings held 27,594 shares of Collegium Pharmaceutical worth $905K as of Q1 2026.
  • HSBC Holdings sold 3,260 Collegium Pharmaceutical shares in Q1 2026, an estimated $138K.
  • Collegium Pharmaceutical made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1924 holding.
  • HSBC Holdings first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 16 quarters since.
  • HSBC Holdings's Collegium Pharmaceutical position peaked at $1.43M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.